Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Breast Cancer Proteomics and Molecular Heterogeneity

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Cancer Trials Ireland
Sponsor:
Information provided by (Responsible Party):
Cancer Trials Ireland
ClinicalTrials.gov Identifier:
NCT01840293
First received: April 23, 2013
Last updated: June 27, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2023 (Final data collection date for primary outcome measure)